NCT04054544View on ClinicalTrials.gov

Gluten Challenge Study in Celiac Disease Participants (MK-0000-402)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

June 23, 2021

Study Completion Date

June 23, 2021

Conditions
Celiac Disease
Interventions
DIETARY_SUPPLEMENT

Gluten powder 4g

Gluten powder 4g oral BID

Trial Locations (2)

02114

Massachusetts General Hospital ( Site 0001), Boston

02215

Beth Israel Deaconess Medical Center ( Site 0002), Boston

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT04054544 - Gluten Challenge Study in Celiac Disease Participants (MK-0000-402) | Biotech Hunter | Biotech Hunter